2018 Louisiana Laws
Revised Statutes
TITLE 40 - Public Health and Safety
RS 40:2255.11 - Disclosure of prescription drug price information

SUBPART B. DISCLOSURE OF PRESCRIPTION DRUG

PRICE INFORMATION

§2255.11. Disclosure of prescription drug price information

            Each drug manufacturer or pharmaceutical marketer who engages in any form of prescription drug marketing to a prescriber, his designee, or any member of his staff in Louisiana shall provide to the Louisiana Board of Pharmacy no later than January first, April first, July first, and October first of each calendar year the current wholesale acquisition cost information for the United States Food and Drug Administration approved drugs marketed in the state by that manufacturer.

            Acts 2017, No. 220, §1.

Disclaimer: These codes may not be the most recent version. Louisiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.